Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peigen Huang, M.D.

Concepts (301)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Peigen Huang's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Peigen Huang has written about over time.
Transplantation, Heterologous, 10 publications between 1989 and 2015, average publication date November 1996. Neoplasm Transplantation, 11 publications between 1990 and 2014, average publication date October 2000. Tumor Cells, Cultured, 10 publications between 1989 and 2021, average publication date May 2002. Glioblastoma, 5 publications between 1995 and 2021, average publication date May 2005. Mice, SCID, 6 publications between 1995 and 2016, average publication date April 2008. Neovascularization, Pathologic, 6 publications between 2003 and 2019, average publication date March 2011. Rodent Diseases, 1 publications between 2011 and 2011, average publication date May 2011. Mice, 49 publications between 1989 and 2023, average publication date June 2011. Radiation Tolerance, 5 publications between 1996 and 2017, average publication date December 2011. Mammary Neoplasms, Experimental, 4 publications between 2004 and 2021, average publication date April 2013. Vascular Endothelial Growth Factor Receptor-2, 4 publications between 2003 and 2019, average publication date May 2013. Neoplasms, Experimental, 3 publications between 2008 and 2019, average publication date March 2014. Receptors, CXCR4, 5 publications between 2011 and 2019, average publication date May 2015. Niacinamide, 3 publications between 2014 and 2017, average publication date July 2015. Losartan, 3 publications between 2013 and 2021, average publication date October 2016. Phenylurea Compounds, 4 publications between 2014 and 2020, average publication date November 2016. Angiotensin II Type 1 Receptor Blockers, 3 publications between 2013 and 2021, average publication date November 2016. Carcinoma, Hepatocellular, 7 publications between 2014 and 2022, average publication date November 2017. Liver Neoplasms, 7 publications between 2014 and 2022, average publication date November 2017. Liver Neoplasms, Experimental, 2 publications between 2015 and 2021, average publication date September 2018.

To see the data from this visualization as text, click here.
Huang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (301)
Explore
_
Co-Authors (71)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.